Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Juan Guzmán de Villoria"'
Autor:
Clara de Andrés, Roseta Teijeiro, Bárbara Alonso, Francisco Sánchez-Madrid, M Luisa Martínez, Juan Guzmán de Villoria, Eduardo Fernández-Cruz, Silvia Sánchez-Ramón
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e34103 (2012)
Myeloid and plasmacytoid dendritic cells (mDCs, pDCs) are central to the initiation and the regulation of immune processes in multiple sclerosis (MS). Natalizumab (NTZ) is a humanized monoclonal antibody approved for the treatment of MS that acts by
Externí odkaz:
https://doaj.org/article/e8409bcf16b04217b4b183af45ff3b6c
Autor:
Marta M. Alonso, Sara García-Duque, Maria Peris-Celda, Josefa Carrión-Navarro, Juan Guzmán-De-Villoria, Carmen Escobedo-Lucea, Cristobal Belda-Iniesta, Susana Esteban-Rubio, Angel Ayuso-Sacido, Noemí García-Romero, Carlos Fernández-Carballal, Ana Ortiz de Mendivil, Elisa Lázaro-Ibáñez, Ricardo Prat-Acín
Publikováno v:
Repositorio Institucional del Instituto Madrileño de Estudios Avanzados en Nanociencia
instname
Oncotarget
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Oncotarget
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
// Noemi Garcia-Romero 1, 2, * , Josefa Carrion-Navarro 1, 3, * , Susana Esteban-Rubio 1, 3, * , Elisa Lazaro-Ibanez 4 , Maria Peris-Celda 5 , Marta M. Alonso 6 , Juan Guzman-De-Villoria 7 , Carlos Fernandez-Carballal 8 , Ana Ortiz de Mendivil 1 , Sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d407f5f5f3c1bff60e399ddfba4c594a
http://hdl.handle.net/20.500.12614/1445
http://hdl.handle.net/20.500.12614/1445
Autor:
Manuel Desco, María Lacalle-Aurioles, Verónica García-Vázquez, Juan Guzmán de Villoria, José Luis Carreras, Javier Olazarán, María Elena Martino, Eloísa Navarro, Isabel Cruz
Publikováno v:
Annals of nuclear medicine. 27(7)
One of the most interesting clinical applications of 18F-FDG PET imaging in neurodegenerative pathologies is that of establishing the prognosis of patients with mild cognitive impairment (MCI), some of whom have a high risk of progressing to Alzheime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84ad5455ee13e98a60b9336262980a0b
https://pubmed.ncbi.nlm.nih.gov/23585159
https://pubmed.ncbi.nlm.nih.gov/23585159
Autor:
Mar Buendía, Angel Bittini, Lourdes Rubio, Joan Muñoz, Gustavo Torres, Antonio Páez, Javier Olazarán, Fernando Anaya, Pilar Ortiz, Mercè Boada, Joan Ramon Grifols, Isabel Hernández, Isabel Roca, Juan Guzmán de Villoria, Isidre Ferrer, Gemma Cuberas, Lluís Tárraga, Laura Núñez
Publikováno v:
Alzheimer's & Dementia. 6
Further, MCI patients also showed decreased BOLD signal in the hippocampus during the delay period when compared to controls. Although MCI patients had diminished neural activity, they performed similarly to controls on the delayed yes/no recognition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::547513d38bede88da6625244befc8f41
https://doi.org/10.1016/j.jalz.2010.05.986
https://doi.org/10.1016/j.jalz.2010.05.986